1,312 results on '"Gastaldelli, Amalia"'
Search Results
2. Methods to Study Metabolomics
3. Brain histone beta-hydroxybutyrylation couples metabolism with gene expression
4. Hepatic, Visceral, Pancreatic, and Cardiac Fat Deposition
5. Insulin sensitivity and beta cell function after duodenal mucosal resurfacing: an open-label, mechanistic, pilot study
6. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
7. Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies
8. Exposure profiles in pregnant women from a birth cohort in a highly contaminated area of southern Italy
9. Lipid metabolism in MASLD and MASH: From mechanism to the clinic
10. Altered fatty acid metabolism rewires cholangiocarcinoma stemness features
11. A global research priority agenda to advance public health responses to fatty liver disease
12. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
13. Methods to Study Metabolomics
14. Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
15. WED-263 A machine learning approach to identify patient features associated with metabolic dysfunction-associated steatohepatitis from the United Kingdom biobank
16. THU-286 PNPLA3 p.I148M variant affects lipid droplets number and size in patient-derived liver organoids
17. Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes
18. Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
19. Prandial hepatic glucose production during hypoglycemia is altered after gastric bypass surgery and sleeve gastrectomy
20. High exposure to phthalates is associated with HbA1c worsening in type 2 diabetes subjects with and without edentulism: a prospective pilot study
21. Insulin: The master regulator of glucose metabolism
22. Autoantibodies against the glial glutamate transporter GLT1/EAAT2 in Type 1 diabetes mellitus—Clues to novel immunological and non-immunological therapies
23. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
24. GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss.
25. Why does obesity cause diabetes?
26. TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models
27. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
28. Disparity-filtered differential correlation network analysis: a case study on CRC metabolomics
29. Differential effect of endogenous glucagon‐like peptide‐1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery
30. Clusters of adipose tissue dysfunction in adults with type 2 diabetes identify those with worse lipidomic profile despite similar glycaemic control
31. Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial
32. Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
33. Metabolic, reproductive and thyroid effects of bis(2-ethylhexyl) phthalate (DEHP) orally administered to male and female juvenile rats at dose levels derived from children biomonitoring study
34. Healthy aging: the INTECMAN project
35. Liver-targeting drugs and their effect on blood glucose and hepatic lipids
36. A global action agenda for turning the tide on fatty liver disease
37. ForePass endoscopic bypass device for obesity and insulin resistance-metabolic treatment in a swine model
38. The role of the liver in the modulation of glucose and insulin in non alcoholic fatty liver disease and type 2 diabetes
39. The Effects of Long-Term High Fat and/or High Sugar Feeding on Sources of Postprandial Hepatic Glycogen and Triglyceride Synthesis in Mice.
40. Urinary Bisphenol A and Bis(2-Ethylhexyl) Phthalate Metabolite Concentrations in Children with Obesity: A Case-Control Study.
41. Vagal activation alters prandial bile acid composition and glycemia in patients with hypoglycemia after Roux‐en‐Y gastric bypass surgery.
42. Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?
43. Metabolic dysfunction-associated fatty liver disease: a year in review
44. Pathogenesis
45. ForePass endoscopic bypass device for obesity and insulin resistance—metabolic treatment in a swine model
46. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
47. Insulin sensitivity depends on the route of glucose administration
48. Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity
49. From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
50. The imprinted gene Delta like non-canonical notch ligand 1 (Dlk1) associates with obesity and triggers insulin resistance through inhibition of skeletal muscle glucose uptake
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.